• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Introduction to 7-Bromo-3-iodo-1H-indole (CAS No. 793727-95-4) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

7-Bromo-3-iodo-1H-indole, identified by the chemical identifier CAS No. 793727-95-4, is a heterocyclic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its versatile structural framework and potential biological activities. This compound belongs to the indole family, which is well-documented for its pharmacological relevance, with numerous indole derivatives exhibiting antimicrobial, anti-inflammatory, and anticancer properties. The presence of both bromo and iodo substituents in the molecule imparts unique reactivity, making it a valuable scaffold for further functionalization and drug discovery initiatives.

The structural motif of 7-Bromo-3-iodo-1H-indole features a bromine atom at the 7-position and an iodine atom at the 3-position of the indole ring. This specific substitution pattern enhances its utility as a building block in synthetic chemistry, particularly in cross-coupling reactions such as Suzuki-Miyaura, Stille, and Sonogashira couplings. These reactions are pivotal in constructing complex molecular architectures, enabling the development of novel therapeutic agents. The electrophilic nature of the halogen atoms facilitates their participation in various chemical transformations, making this compound a preferred choice for medicinal chemists seeking to explore new drug candidates.

In recent years, 7-Bromo-3-iodo-1H-indole has been extensively utilized in the synthesis of bioactive molecules with targeted pharmacological effects. One notable area of research involves its application in developing small-molecule inhibitors for kinases and other enzyme targets implicated in cancer progression. The indole core is a common pharmacophore in kinase inhibitors due to its ability to interact with ATP-binding pockets and modulate enzyme activity. Researchers have leveraged 7-Bromo-3-iodo-1H-indole as a precursor to generate derivatives with enhanced binding affinity and selectivity against specific kinases. For instance, studies have demonstrated its role in synthesizing inhibitors of cyclin-dependent kinases (CDKs) and tyrosine kinases (TKs), which are critical regulators of cell cycle progression and signal transduction pathways.

Another emerging application of 7-Bromo-3-iodo-1H-indole lies in its use as a scaffold for antimicrobial agents. The indole scaffold is known to exhibit broad-spectrum antimicrobial activity, attributed to its ability to disrupt bacterial cell membranes and interfere with vital metabolic processes. By incorporating halogen atoms such as bromine and iodine, researchers can fine-tune the electronic properties of the molecule, enhancing its interaction with bacterial targets. Recent studies have highlighted the potential of 7-Bromo-3-iodo-1H-indole derivatives as novel antibiotics against multidrug-resistant bacterial strains. The halogen substituents facilitate additional derivatization strategies, allowing chemists to optimize solubility, bioavailability, and pharmacokinetic profiles.

The compound's utility extends beyond anticancer and antimicrobial applications; it has also been explored in neurodegenerative disease research. Indole derivatives are known to modulate neurotransmitter systems and exhibit neuroprotective effects. For example, modifications of 7-Bromo-3-iodo-1H-indole have led to the discovery of compounds that show promise in alleviating symptoms associated with Alzheimer's disease by inhibiting beta-secretase activity—a key enzyme involved in amyloid-beta peptide production. The bromo and iodo substituents provide handles for further chemical modifications, enabling the development of more potent and selective neuroprotective agents.

Advances in computational chemistry have further enhanced the strategic use of 7-Bromo-3-iodo-1H-indole in drug design. Molecular modeling studies have identified key interactions between indole derivatives and biological targets, guiding rational design efforts. For instance, virtual screening techniques have been employed to predict binding affinities of 7-Bromo-3-iodo-1H-indole derivatives with protein targets such as bromodomain-containing proteins (BRDs), which are implicated in various cancers and inflammatory diseases. These computational approaches have accelerated the discovery pipeline by prioritizing promising candidates for experimental validation.

The synthetic versatility of 7-Bromo-3-iodo-1H-indole has also been exploited in materials science applications. Indole-based polymers exhibit unique optoelectronic properties, making them suitable for organic light-emitting diodes (OLEDs) and photovoltaic devices. Researchers have incorporated 7-Bromo-3-iodo-1H-indole into polymer backbones to enhance charge transport properties, leading to improved device performance. The halogen substituents contribute to tunable energy levels, enabling fine-tuning of material characteristics for specific applications.

In conclusion,7-Bromo-3 iod o -1 H -ind ole (CAS No .79 372 7 -95 -4 ) is a multifaceted compound with significant potential across multiple domains of chemical biology and medicinal chemistry . Its structural features , coupled with its reactivity , make it an invaluable scaffold for designing novel therapeutic agents . Ongoing research continues to uncover new applications , reinforcing its importance as a cornerstone molecule in drug discovery initiatives . As synthetic methodologies advance , the utility of this compound is expected to expand even further , driving innovation in pharmaceutical development . p >

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)